Neuraxpharm and partner Minoryx Therapeutics, meanwhile, were unable to convince the CHMP that they should get conditional approval for PPAR gamma agonist Nezglyal (leriglitazone) as a treatment ...

The Scientific Advisory Group (SAG) has been called in to assist the EMA’s CHMP human medicines committee in its review of the drug, which is vying to become the first disease-modifying therapy ...

In a world where career paths are often linear, Morten Holm, a 56-year-old Danish architect, exemplifies the dynamic "slash" lifestyle, seamlessly transitioning from architect to urban designer ...

March 25 @ 6:00 am - 7:30 am EDT ...

The RA Architecture Prize and The RA Dorfman Prize celebrate outstanding international contributions to design and uncover fresh new talent. Hear from leading architects from the UK and around the ...

21 March 2025 China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou ...